Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
Adam Winstock, Michael Lynskey, Rohan Borschmann, Jon Waldron
Journal of Psychopharmacology | SAGE PUBLICATIONS LTD | Published : 2015
BACKGROUND: Synthetic cannabinoids (SCs) have become increasingly popular in recent years. Diverse in chemical structure, many have been subjected to legislative regulation, but their availability and use persists. Often marketed to reflect their similar effects to cannabis, their use has been associated with a range of negative health effects. We sought to determine the relative risk of seeking emergency medical treatment (EMT) following use of SCs and natural cannabis. METHODS: We utilized an anonymous online survey of drug use, obtaining data from 22,289 respondents. We calculated the relative risk of seeking EMT between the two substances using an estimate for days used in the past year...View full abstract
Global Drug Survey Ltd is an independent self-funded organization. The authors received no financial support for the research, authorship, and/or publication of this article.